Marex Group’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.67M Sell
180,179
-21,165
-11% -$946K 0.03% 202
2026
Q1
$8.15M Buy
201,344
+2,302
+1% +$102K 0.05% 174
2025
Q4
$9.13M Sell
199,042
-100
-0.1% -$4.56K 0.06% 164
2025
Q3
$9.1M Buy
199,142
+160,599
+417% +$7.12M 0.06% 148
2025
Q2
$1.59M Sell
38,543
-157,650
-80% -$5.84M 0.01% 248
2025
Q1
$6.85M Buy
196,193
+13,793
+8% +$521K 0.13% 89
2024
Q4
$6.99M Hold
182,400
0.12% 88
2024
Q3
$6.46M Buy
+182,400
New +$5.76M 0.15% 84

Other funds holding BN

Marex Group's BN Position: Q2 2026 in Review

Marex Group reduced its Brookfield (BN) stake by 11% in Q2 2026, selling an estimated $946K and leaving 180,179 shares worth $7.67M. The position accounts for 0.03% of the portfolio, ranked #202.

Marex Group first reported a position in BN in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.13M in Q4 2025. 941 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Marex Group held 180,179 shares of Brookfield worth $7.67M as of Q2 2026.
  • Marex Group sold 21,165 Brookfield shares in Q2 2026, an estimated $946K.
  • Brookfield made up 0.03% of Marex Group's portfolio in Q2 2026, its #202 holding.
  • Marex Group first reported a position in Brookfield in Q3 2024 and has held it in 8 quarters since.
  • Marex Group's Brookfield position peaked at $9.13M in Q4 2025.
  • 941 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.